Insights

Blog

Reflections on 2020 and an Optimistic Outlook for the Year Ahead

By Jesse Klein, Jason Hersh, and Josh Albert We’ve just reached the end of a year unlike any other. As we look back on challenges faced and what has been accomplished over the last 12 months, there are many things to take with us into 2021. We continued to be amazed by the pace of scientific discovery.  The value of ...
Blog

The Cell and Gene Therapy Revolution

A conversation with Klein Hersh’s Hillary Kaplan Even as the global biopharma industry urgently focuses on combatting COVID-19, the cell/gene therapy sector marches onward, experiencing strong growth and expansion. The sector has continued its rapid progression into one of the industry’s hottest markets, spurred on by robust venture capital investment in new company formation and ongoing strategic acquisitions by big ...
September 24, 2020
Blog

Common Questions in the Search Process: Advice for Candidates

In helping organizations across the healthcare industry build their analytics and data science teams, I’ve had the opportunity to connect with thousands of job candidates. During these countless conversations, I’ve come across some tough, but common questions that many candidates have, but are unsure how to address with prospective employers. Here are answers to five commonly asked questions that candidates ...
September 10, 2020
Blog

The Skyrocketing Growth of Telehealth: The Healthcare Sector Adapts to Change Amid COVID-19

There is no doubt that we are all living history as we face the COVID-19 pandemic. And while every industry has been impacted by this enormous global challenge, there are some, particularly those surrounding healthcare and technology, that are experiencing record surge due to significant need. Telehealth and virtual care have been brewing in the background for years, but the ...
July 8, 2020
Blog

Changing Role of the Quality Professional in Pharma’s New Era

Drug discovery and manufacturing is rapidly changing across the pharmaceutical industry. The increased focus on rare diseases, along with breakthroughs in biologics, gene and cell therapy, and other forms of personalized medicine, have empowered bold innovation among drug developers. Many companies are leveraging these scientific advancements to pursue a new aspirational focus on finding cures for the most-difficult-to-treat diseases. As ...
January 18, 2020
Blog

Meeting the Growing Talent Demand in Cell and Gene Therapy & Biologics

Boom in cell and gene therapy Among these segments is cell and gene therapy, where innovative science in areas such as cardiovascular disease, cancer, and genetic disorders is driving rapid R&D activity to address critical unmet patient needs. Recent scientific successes in cell and gene therapy are fostering robust venture investment in start-ups, as well as a flurry of mergers ...
October 1, 2019